Product
SHR-A1921
Name
SHR-A1921
1 clinical trial
1 indication
Indication
NSCLCClinical trial
An Exploratory Clinical Study of SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line TreatmentStatus: Not yet recruiting, Estimated PCD: 2027-06-15